Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11576
CALL
Liberty Global Class C
LBTYK
$3.49B
| $73.4K | ﹤0.01% |
3,600
-31,800
| -90% | -$670K |
|
11577
PUT
Lantronix
LTRX
$289M
| $73.3K | ﹤0.01% |
16,900
+700
| +4% | +$3.28K |
|
11578
Edison International
EIX
$27.5B
| $73.3K | ﹤0.01% |
1,039
+994
| +2,209% | +$67.1K |
|
11579
CALL
SCYNEXIS
SCYX
$51.5M
| $73.2K | ﹤0.01% |
3,050
-1,225
| -29% | -$16.3K |
|
11580
PUT
Superior Group of Companies
SGC
$208M
| $73.2K | ﹤0.01% |
9,300
+2,400
| +35% | +$25.8K |
|
11581
PUT
iShares Micro-Cap ETF
IWC
$1.52B
| $73.2K | ﹤0.01% |
700
+100
| +17% | +$11.2K |
|
|
PRPH
11582
PUT
DELISTED
ProPhase Labs
PRPH
| $73.2K | ﹤0.01% |
960
-310
| -24% | -$25K |
|
|
REVG
11583
CALL
DELISTED
REV Group
REVG
| $73.1K | ﹤0.01% |
6,100
+700
| +13% | +$8.72K |
|
11584
CALL
NextCure
NXTC
$37.6M
| $73.1K | ﹤0.01% |
4,117
-1,000
| -20% | -$19.3K |
|
|
AEY
11585
DELISTED
ADDvantage Technologies Group
AEY
| $73.1K | ﹤0.01% |
6,583
+458
| +7% | +$6.45K |
|
11586
Quad
QUAD
$513M
| $72.9K | ﹤0.01% |
+16,995
| New | +$74.9K |
|
11587
PUT
Invesco CurrencyShares Australian Dollar Trust
FXA
$98.2M
| $72.8K | ﹤0.01% |
1,100
-3,200
| -74% | -$216K |
|
|
GOGL
11588
DELISTED
Golden Ocean Group
GOGL
| $72.8K | ﹤0.01% |
7,648
-11,507
| -60% | -$109K |
|
11589
CALL
Eton Pharmaceutcials
ETON
$1.68B
| $72.8K | ﹤0.01% |
+18,900
| New | +$68.9K |
|
11590
CALL
The Honest Company
HNST
$519M
| $72.7K | ﹤0.01% |
40,400
-4,600
| -10% | -$12.6K |
|
11591
Eledon Pharmaceuticals
ELDN
$288M
| $72.7K | ﹤0.01% |
+30,810
| New | +$82.6K |
|
11592
PUT
NextDecade
NEXT
$1.91B
| $72.6K | ﹤0.01% |
14,600
-17,100
| -54% | -$99.4K |
|
11593
Vor Biopharma
VOR
$1.36B
| $72.5K | ﹤0.01% |
674
-747
| -53% | -$82.8K |
|
11594
CALL
FreightCar America
RAIL
$240M
| $72.4K | ﹤0.01% |
23,200
-6,000
| -21% | -$20.7K |
|
11595
CALL
Torrid Holdings
CURV
$219M
| $72.4K | ﹤0.01% |
16,600
-100
| -0.6% | -$317 |
|
|
NAGE
11596
CALL
Niagen Bioscience
NAGE
$239M
| $72.4K | ﹤0.01% |
47,300
-43,000
| -48% | -$76.6K |
|
|
EEX
11597
DELISTED
Emerald Holding
EEX
| $72.4K | ﹤0.01% |
19,451
-3,650
| -16% | -$13.6K |
|
11598
Broadway Financial
BYFC
$111M
| $72.4K | ﹤0.01% |
+8,614
| New | +$81.1K |
|
11599
CALL
Sasol
SSL
$7.39B
| $72.3K | ﹤0.01% |
5,300
+2,200
| +71% | +$34.2K |
|
11600
CALL
DLH Holdings
DLHC
$67.5M
| $72.3K | ﹤0.01% |
6,300
-2,300
| -27% | -$27.5K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.